Human C-Reactive Protein (CRP) for clinical research
Human C-Reactive Protein (CRP) for clinical research. The prescence of C-Reactive Protein in the blood indicates an increased state of inflammation, the normal response to a number of physical states including fever, injury and infection. Inflammation is also believed to play a role in the initiation and progression of cardiovascular disease. CRP studies have shown that baseline Human CRP concentrations are not subject to time-of-day variation and, therefore, help explain why CRP concentrations are a better predictor of vascular risk than interleukin-6. Determination of CRP for cardiovascular risk prediction may be performed without concern for diumal variation. According to the National Academy of Clinical Biochemistry's reports on Human CRP, increased concentrations of inflammatory biomarkers such as Human C-Reactive Protein CRP, serum Amyloid A, myeloperoxidase and interleukin-6 are detectable in ACS (acute coronary syndrome) patients. High quality human CRP is available from Lee Biosolutions for use in clinical research. Human C-Reactive Protein (CRP) for clinical research
Lee Biosolutions Inc
